id
int64
1
100k
graph_name
stringclasses
1 value
schema
stringclasses
1 value
input
stringlengths
43
565
output
stringlengths
122
887
99,901
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies conducted by Quadras Scientific Solutions in Hangzhou, Zhejiang, China involving Pulmonary Tuberculoses and BDP HFA Nasal Aerosol. Include collaborators and outcome details.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Quadras Scientific Solutions'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Pulmonary Tuberculoses'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'BDP HFA Nasal Aerosol'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,902
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies conducted by Quadras Scientific Solutions involving Intervertebral Disc Disorder Lumbar With Radiculopathy and Placebo to SHP-141C in San Francisco. Who collaborated, and what were the outcomes?
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Quadras Scientific Solutions'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'San Francisco'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Intervertebral Disc Disorder Lumbar With Radiculopathy'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Placebo to SHP-141C'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,903
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies supported by J&J in Kristianstad, Sweden that investigated Thalassemia Intermedia and Recombinant new coronavirus vaccine (CHO cell) low-dose group. Include details of primary and secondary outcomes.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'J&J'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Thalassemia Intermedia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Recombinant new coronavirus vaccine (CHO cell) low-dose group'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,904
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Which studies funded by INDIV in PHASE1 were conducted at Los Angeles and involved Ventricular Ectopic Beat(S) as well as Gelfoam? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators?
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ventricular Ectopic Beat(S)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,905
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Find studies supported by NIH in PHASE3 at Chicago. Include Ventricular Ectopic Beat(S), Recombinant new coronavirus vaccine (CHO cell) low-dose group, primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ventricular Ectopic Beat(S)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Recombinant new coronavirus vaccine (CHO cell) low-dose group'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,906
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies in PHASE2 funded by FED at New York involving Ischemic Heart Disease (IHD) and diet and exercise. Include outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'FED'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'New York'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ischemic Heart Disease (IHD)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'diet and exercise'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,907
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies sponsored by Pfizer in Chicago that studied Intervertebral Disc Disorder Lumbar With Radiculopathy and Gelfoam. Include primary and secondary outcomes.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Pfizer'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Intervertebral Disc Disorder Lumbar With Radiculopathy'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,908
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
What studies were conducted by Pfizer in New York and involved Orthodontic Retainers as well as TQ-A3334? What were the primary and secondary outcomes?
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Pfizer'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'New York'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Orthodontic Retainers'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'TQ-A3334'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,909
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies funded by UNKNOWN in PHASE1 at Los Angeles involving Laryngeal Dystonia and Active MBM. Include details of outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'UNKNOWN'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,910
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies conducted by Vancouver Prostate Centre in Chicago involving Human Flu and Amivantamab (to be determined). Include collaborators and outcome details.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Vancouver Prostate Centre'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Amivantamab (to be determined)'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,911
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies funded by AMBIG in PHASE1 at Kristianstad, Sweden that involved Ventricular Ectopic Beat(S) and 10 % lidocaine spray without adrenaline. Include primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ventricular Ectopic Beat(S)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: '10 % lidocaine spray without adrenaline'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,912
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Find studies supported by UNKNOWN in PHASE2|PHASE3 at Lund, Sweden. Include Ketamine Treatment, delandistrogene moxeparvovec, primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'UNKNOWN'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ketamine Treatment'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'delandistrogene moxeparvovec'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,913
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Find studies supported by OTHER_GOV in EARLY_PHASE1 at Helsingborg, Sweden. Include Post Cardiac Surgery, Mayo Clinic Foregut Surgery Report Card Questionnaire, primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER_GOV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Post Cardiac Surgery'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Mayo Clinic Foregut Surgery Report Card Questionnaire'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,914
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies conducted by NSABP Foundation Inc involving Chronic Antibody-mediated Transplant Rejection and TQ-A3334 in Boston. Who collaborated, and what were the outcomes?
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'NSABP Foundation Inc'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'TQ-A3334'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,915
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies with Human Flu in PHASE3 funded by FED, involving BDP HFA Nasal Aerosol. What were the primary and secondary outcomes, and who collaborated and sponsored them?
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'FED'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'BDP HFA Nasal Aerosol'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,916
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies conducted by Quadras Scientific Solutions in Helsingborg, Sweden involving Recurrent Hypopharyngeal Squamous Cell Carcinoma and TQ-A3334. Include collaborators and outcome details.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Quadras Scientific Solutions'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'TQ-A3334'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,917
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies supported by J&J that involved Recurrent Hypopharyngeal Squamous Cell Carcinoma and relaxation response- meditation in Hangzhou, Zhejiang, China. Include collaborators and outcomes.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'J&J'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'relaxation response- meditation'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,918
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies supported by NSABP Foundation Inc in Los Angeles that investigated Alpha1-antitrypsin Deficiency and 10 % lidocaine spray without adrenaline. Include details of primary and secondary outcomes.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'NSABP Foundation Inc'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Alpha1-antitrypsin Deficiency'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: '10 % lidocaine spray without adrenaline'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,919
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Find studies supported by NIH in PHASE1|PHASE2 at Hangzhou, Zhejiang, China. Include Thalassemia Intermedia, Nalmefene (Selincro®) 18 mg tablet, primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1|PHASE2'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Thalassemia Intermedia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Nalmefene (Selincro®) 18 mg tablet'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,920
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies in PHASE3 funded by FED at San Francisco involving Laryngeal Dystonia and relaxation response- meditation. Include outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'FED'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'San Francisco'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'relaxation response- meditation'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,921
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Which studies funded by AMBIG in PHASE1|PHASE2 were conducted at San Francisco and involved Human Flu as well as diet and exercise? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators?
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1|PHASE2'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'San Francisco'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'diet and exercise'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,922
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies conducted by Pfizer in Kristianstad, Sweden involving Laryngeal Dystonia and relaxation response- meditation. Include collaborators and outcome details.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Pfizer'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'relaxation response- meditation'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,923
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies funded by OTHER_GOV in PHASE2 at Hangzhou, Zhejiang, China that involved Ventricular Ectopic Beat(S) and Gelfoam. Include primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER_GOV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ventricular Ectopic Beat(S)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,924
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies in PHASE1 funded by OTHER at Lund, Sweden involving Pulmonary Tuberculoses and diet and exercise. Include outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Pulmonary Tuberculoses'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'diet and exercise'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,925
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Which studies funded by INDIV in EARLY_PHASE1 were conducted at San Francisco and involved Chorea Associated With Huntington Disease as well as Guided bone regeneration? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators?
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'San Francisco'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chorea Associated With Huntington Disease'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Guided bone regeneration'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,926
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies funded by INDIV in PHASE1|PHASE2 at Lund, Sweden involving Intervertebral Disc Disorder Lumbar With Radiculopathy and Recombinant new coronavirus vaccine (CHO cell) low-dose group. Include details of outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1|PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Intervertebral Disc Disorder Lumbar With Radiculopathy'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Recombinant new coronavirus vaccine (CHO cell) low-dose group'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,927
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Find studies supported by NETWORK in PHASE4 at Chicago. Include Neurocognitive Dysfunction, pulmonory based home exercises, primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE4'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Neurocognitive Dysfunction'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,928
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies funded by INDIV in EARLY_PHASE1 at Boston that involved Hand Injuries and Gelfoam. Include primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Hand Injuries'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,929
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies with Neurocognitive Dysfunction in PHASE4 funded by NETWORK, involving Placebo to SHP-141C. What were the primary and secondary outcomes, and who collaborated and sponsored them?
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE4'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Neurocognitive Dysfunction'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Placebo to SHP-141C'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,930
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies with Intervertebral Disc Disorder Lumbar With Radiculopathy in PHASE4 funded by AMBIG, involving Mayo Clinic Foregut Surgery Report Card Questionnaire. What were the primary and secondary outcomes, and who collaborated and sponsored them?
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE4'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Intervertebral Disc Disorder Lumbar With Radiculopathy'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Mayo Clinic Foregut Surgery Report Card Questionnaire'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,931
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies supported by NSABP Foundation Inc that involved Neurocognitive Dysfunction and BLOOD SAMPLE in Los Angeles. Include collaborators and outcomes.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'NSABP Foundation Inc'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Neurocognitive Dysfunction'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'BLOOD SAMPLE'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,932
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies funded by INDIV in PHASE2|PHASE3 at Los Angeles involving Chronic Antibody-mediated Transplant Rejection and Recombinant new coronavirus vaccine (CHO cell) low-dose group. Include details of outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Recombinant new coronavirus vaccine (CHO cell) low-dose group'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,933
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies conducted by NSABP Foundation Inc in Chicago involving Post Cardiac Surgery and Placebo to SHP-141C. Include collaborators and outcome details.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'NSABP Foundation Inc'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Post Cardiac Surgery'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Placebo to SHP-141C'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,934
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Which studies funded by INDIV in PHASE3 were conducted at Boston and involved Chronic Antibody-mediated Transplant Rejection as well as Plasma? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators?
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Plasma'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,935
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies conducted by Novartis involving Bleeding Cardiac Surgery Patients and TQ-A3334 in Los Angeles. Who collaborated, and what were the outcomes?
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Novartis'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Bleeding Cardiac Surgery Patients'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'TQ-A3334'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,936
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
What studies were conducted by Quadras Scientific Solutions in New York and involved Chronic Antibody-mediated Transplant Rejection as well as Combination therapy (S81694 + paclitaxel) phase I? What were the primary and secondary outcomes?
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Quadras Scientific Solutions'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'New York'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Combination therapy (S81694 + paclitaxel) phase I'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,937
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies conducted by Vancouver Prostate Centre involving Human Flu and Gelfoam in Helsingborg, Sweden. Who collaborated, and what were the outcomes?
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Vancouver Prostate Centre'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,938
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Which studies funded by UNKNOWN in PHASE3 were conducted at Chicago and involved Ischemic Heart Disease (IHD) as well as Placebo to SHP-141C? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators?
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'UNKNOWN'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ischemic Heart Disease (IHD)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Placebo to SHP-141C'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,939
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies with Laryngeal Dystonia in PHASE1 funded by OTHER, involving Nalmefene (Selincro®) 18 mg tablet. What were the primary and secondary outcomes, and who collaborated and sponsored them?
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Nalmefene (Selincro®) 18 mg tablet'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,940
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies with Pulmonary Tuberculoses in PHASE3 funded by NIH, involving Gelfoam. What were the primary and secondary outcomes, and who collaborated and sponsored them?
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Pulmonary Tuberculoses'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,941
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies supported by IHF GmbH - Institut für Herzinfarktforschung in Kristianstad, Sweden that investigated Pulmonary Tuberculoses and diet and exercise. Include details of primary and secondary outcomes.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'IHF GmbH - Institut für Herzinfarktforschung'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Pulmonary Tuberculoses'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'diet and exercise'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,942
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies in PHASE3 funded by UNKNOWN at Chicago involving Human Flu and pulmonory based home exercises. Include outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'UNKNOWN'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,943
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Which studies funded by OTHER in EARLY_PHASE1 were conducted at New York and involved Recurrent Hypopharyngeal Squamous Cell Carcinoma as well as Weight loss? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators?
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'New York'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Weight loss'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,944
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies funded by FED in PHASE3 at Lund, Sweden that involved Ischemic Heart Disease (IHD) and diet and exercise. Include primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'FED'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ischemic Heart Disease (IHD)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'diet and exercise'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,945
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Which studies funded by NETWORK in PHASE3 were conducted at Chicago and involved Bleeding Cardiac Surgery Patients as well as Gelfoam? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators?
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Bleeding Cardiac Surgery Patients'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,946
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies supported by NSABP Foundation Inc in Hangzhou, Zhejiang, China that investigated Leukemia Relapse and TQ-A3334. Include details of primary and secondary outcomes.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'NSABP Foundation Inc'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Leukemia Relapse'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'TQ-A3334'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,947
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies sponsored by Quadras Scientific Solutions in Chicago that studied Pulmonary Tuberculoses and pulmonory based home exercises. Include primary and secondary outcomes.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Quadras Scientific Solutions'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Pulmonary Tuberculoses'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,948
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Find studies supported by AMBIG in EARLY_PHASE1 at Helsingborg, Sweden. Include Bleeding Cardiac Surgery Patients, Nalmefene (Selincro®) 18 mg tablet, primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Bleeding Cardiac Surgery Patients'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Nalmefene (Selincro®) 18 mg tablet'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,949
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
What studies were conducted by IHF GmbH - Institut für Herzinfarktforschung in Kristianstad, Sweden and involved Ventricular Ectopic Beat(S) as well as Amivantamab (to be determined)? What were the primary and secondary outcomes?
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'IHF GmbH - Institut für Herzinfarktforschung'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ventricular Ectopic Beat(S)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Amivantamab (to be determined)'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,950
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Find studies supported by OTHER in PHASE2|PHASE3 at Lund, Sweden. Include Thalassemia Intermedia, delandistrogene moxeparvovec, primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Thalassemia Intermedia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'delandistrogene moxeparvovec'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,951
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies in PHASE2|PHASE3 funded by AMBIG at Lund, Sweden involving Chronic Antibody-mediated Transplant Rejection and TQ-A3334. Include outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'TQ-A3334'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,952
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Find studies supported by OTHER in PHASE3 at Boston. Include Leukemia Relapse, pulmonory based home exercises, primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Leukemia Relapse'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,953
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies with Laryngeal Dystonia in PHASE1|PHASE2 funded by OTHER, involving diet and exercise. What were the primary and secondary outcomes, and who collaborated and sponsored them?
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1|PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'diet and exercise'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,954
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies with Chronic Antibody-mediated Transplant Rejection in PHASE2 funded by NETWORK, involving Active MBM. What were the primary and secondary outcomes, and who collaborated and sponsored them?
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,955
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
What studies were conducted by Vancouver Prostate Centre in Kristianstad, Sweden and involved Chorea Associated With Huntington Disease as well as Amivantamab (to be determined)? What were the primary and secondary outcomes?
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Vancouver Prostate Centre'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chorea Associated With Huntington Disease'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Amivantamab (to be determined)'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,956
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies conducted by Quadras Scientific Solutions in Kristianstad, Sweden involving Hand Injuries and Gelfoam. Include collaborators and outcome details.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Quadras Scientific Solutions'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Hand Injuries'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,957
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Find studies supported by NETWORK in PHASE1|PHASE2 at Hangzhou, Zhejiang, China. Include Hand Injuries, Recombinant new coronavirus vaccine (CHO cell) low-dose group, primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1|PHASE2'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Hand Injuries'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Recombinant new coronavirus vaccine (CHO cell) low-dose group'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,958
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Which studies funded by NETWORK in EARLY_PHASE1 were conducted at Boston and involved Laryngeal Dystonia as well as Recombinant new coronavirus vaccine (CHO cell) low-dose group? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators?
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Recombinant new coronavirus vaccine (CHO cell) low-dose group'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,959
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies with Recurrent Hypopharyngeal Squamous Cell Carcinoma in PHASE3 funded by AMBIG, involving Recombinant new coronavirus vaccine (CHO cell) low-dose group. What were the primary and secondary outcomes, and who collaborated and sponsored them?
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Recombinant new coronavirus vaccine (CHO cell) low-dose group'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,960
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies funded by AMBIG in PHASE2 at Lund, Sweden involving Bleeding Cardiac Surgery Patients and pulmonory based home exercises. Include details of outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Bleeding Cardiac Surgery Patients'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,961
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies funded by AMBIG in PHASE2|PHASE3 at Boston that involved Chorea Associated With Huntington Disease and relaxation response- meditation. Include primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chorea Associated With Huntington Disease'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'relaxation response- meditation'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,962
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies with Laryngeal Dystonia in PHASE1 funded by UNKNOWN, involving Combination therapy (S81694 + paclitaxel) phase I. What were the primary and secondary outcomes, and who collaborated and sponsored them?
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'UNKNOWN'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Combination therapy (S81694 + paclitaxel) phase I'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,963
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies conducted by J&J involving Leukemia Relapse and Nalmefene (Selincro®) 18 mg tablet in Hangzhou, Zhejiang, China. Who collaborated, and what were the outcomes?
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'J&J'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Leukemia Relapse'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Nalmefene (Selincro®) 18 mg tablet'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,964
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies in PHASE2 funded by NIH at Los Angeles involving Laryngeal Dystonia and relaxation response- meditation. Include outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'relaxation response- meditation'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,965
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies funded by AMBIG in PHASE4 at Helsingborg, Sweden involving Thalassemia Intermedia and delandistrogene moxeparvovec. Include details of outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE4'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Thalassemia Intermedia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'delandistrogene moxeparvovec'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,966
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Find studies supported by NIH in PHASE4 at Boston. Include Laryngeal Dystonia, BDP HFA Nasal Aerosol, primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE4'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'BDP HFA Nasal Aerosol'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,967
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies funded by UNKNOWN in PHASE2 at Hangzhou, Zhejiang, China that involved Ventricular Ectopic Beat(S) and relaxation response- meditation. Include primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'UNKNOWN'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ventricular Ectopic Beat(S)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'relaxation response- meditation'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,968
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies supported by IHF GmbH - Institut für Herzinfarktforschung in Helsingborg, Sweden that investigated Thalassemia Intermedia and Amivantamab (to be determined). Include details of primary and secondary outcomes.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'IHF GmbH - Institut für Herzinfarktforschung'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Thalassemia Intermedia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Amivantamab (to be determined)'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,969
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies in PHASE3 funded by INDIV at Chicago involving Post Cardiac Surgery and Plasma. Include outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Post Cardiac Surgery'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Plasma'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,970
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies funded by NIH in PHASE2 at San Francisco involving Post Cardiac Surgery and Combination therapy (S81694 + paclitaxel) phase I. Include details of outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'San Francisco'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Post Cardiac Surgery'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Combination therapy (S81694 + paclitaxel) phase I'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,971
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies conducted by Quadras Scientific Solutions in Lund, Sweden involving Refractory Pulmonary Edema and Active MBM. Include collaborators and outcome details.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Quadras Scientific Solutions'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Refractory Pulmonary Edema'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,972
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies conducted by Peter Rossing in New York involving Thalassemia Intermedia and BDP HFA Nasal Aerosol. Include collaborators and outcome details.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Peter Rossing'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'New York'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Thalassemia Intermedia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'BDP HFA Nasal Aerosol'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,973
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Find studies supported by OTHER_GOV in PHASE2|PHASE3 at Boston. Include Chronic Antibody-mediated Transplant Rejection, Gelfoam, primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER_GOV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,974
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Find studies supported by INDIV in PHASE3 at Los Angeles. Include Pulmonary Tuberculoses, delandistrogene moxeparvovec, primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Pulmonary Tuberculoses'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'delandistrogene moxeparvovec'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,975
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies supported by Novartis in San Francisco that investigated Ischemic Heart Disease (IHD) and EHR clinical decision support nudges. Include details of primary and secondary outcomes.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Novartis'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'San Francisco'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ischemic Heart Disease (IHD)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'EHR clinical decision support nudges'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,976
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies with Post Cardiac Surgery in PHASE3 funded by NIH, involving Nalmefene (Selincro®) 18 mg tablet. What were the primary and secondary outcomes, and who collaborated and sponsored them?
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Post Cardiac Surgery'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Nalmefene (Selincro®) 18 mg tablet'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,977
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies with Leukemia Relapse in PHASE2|PHASE3 funded by NIH, involving Active MBM. What were the primary and secondary outcomes, and who collaborated and sponsored them?
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Leukemia Relapse'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,978
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies funded by OTHER_GOV in PHASE2 at Hangzhou, Zhejiang, China involving Ventricular Ectopic Beat(S) and diet and exercise. Include details of outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER_GOV'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ventricular Ectopic Beat(S)'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'diet and exercise'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,979
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Find studies supported by AMBIG in EARLY_PHASE1 at Hangzhou, Zhejiang, China. Include Ketamine Treatment, Active MBM, primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'AMBIG'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Ketamine Treatment'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,980
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
What studies were conducted by Vancouver Prostate Centre in New York and involved Human Flu as well as pulmonory based home exercises? What were the primary and secondary outcomes?
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Vancouver Prostate Centre'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'New York'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,981
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies funded by INDUSTRY in PHASE1 at Kristianstad, Sweden involving Human Flu and pulmonory based home exercises. Include details of outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDUSTRY'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,982
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies sponsored by Vancouver Prostate Centre in Helsingborg, Sweden that studied Refractory Pulmonary Edema and Active MBM. Include primary and secondary outcomes.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Vancouver Prostate Centre'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Refractory Pulmonary Edema'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,983
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies with Recurrent Hypopharyngeal Squamous Cell Carcinoma in PHASE4 funded by NIH, involving EHR clinical decision support nudges. What were the primary and secondary outcomes, and who collaborated and sponsored them?
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE4'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'EHR clinical decision support nudges'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,984
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Identify studies with Chronic Antibody-mediated Transplant Rejection in PHASE3 funded by UNKNOWN, involving Combination therapy (S81694 + paclitaxel) phase I. What were the primary and secondary outcomes, and who collaborated and sponsored them?
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'UNKNOWN'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Combination therapy (S81694 + paclitaxel) phase I'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,985
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies funded by INDIV in PHASE1|PHASE2 at Helsingborg, Sweden that involved Laryngeal Dystonia and Active MBM. Include primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDIV'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1|PHASE2'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,986
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies sponsored by Novartis in San Francisco that studied Post Cardiac Surgery and Active MBM. Include primary and secondary outcomes.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Novartis'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'San Francisco'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Post Cardiac Surgery'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,987
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Which studies funded by FED in EARLY_PHASE1 were conducted at Boston and involved Human Flu as well as Guided bone regeneration? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators?
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'FED'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'EARLY_PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Guided bone regeneration'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,988
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Which studies funded by INDUSTRY in PHASE3 were conducted at Chicago and involved Laryngeal Dystonia as well as Active MBM? What were the primary and secondary outcomes, who sponsored them, and who were the collaborators?
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDUSTRY'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Chicago'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Active MBM'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,989
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies funded by INDUSTRY in PHASE2|PHASE3 at Lund, Sweden that involved Kidney Carcinoma and delandistrogene moxeparvovec. Include primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDUSTRY'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Kidney Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'delandistrogene moxeparvovec'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,990
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Find studies supported by NIH in PHASE1 at Lund, Sweden. Include Recurrent Hypopharyngeal Squamous Cell Carcinoma, pulmonory based home exercises, primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NIH'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'pulmonory based home exercises'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,991
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies in PHASE2 funded by OTHER at Boston involving Recurrent Hypopharyngeal Squamous Cell Carcinoma and relaxation response- meditation. Include outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'relaxation response- meditation'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,992
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
What studies were conducted by J&J in Los Angeles and involved Recurrent Hypopharyngeal Squamous Cell Carcinoma as well as Gelfoam? What were the primary and secondary outcomes?
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'J&J'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Gelfoam'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) RETURN study.title, primary.name AS primary_outcome, secondary.name AS secondary_outcome
99,993
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies funded by FED in PHASE2 at Helsingborg, Sweden that involved Human Flu and delandistrogene moxeparvovec. Include primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'FED'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Human Flu'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'delandistrogene moxeparvovec'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,994
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies conducted by Novartis in Los Angeles involving Thalassemia Intermedia and delandistrogene moxeparvovec. Include collaborators and outcome details.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Novartis'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Los Angeles'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Thalassemia Intermedia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'delandistrogene moxeparvovec'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,995
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Find studies supported by NETWORK in PHASE2|PHASE3 at Boston. Include Chronic Antibody-mediated Transplant Rejection, Plasma, primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE2|PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Boston'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chronic Antibody-mediated Transplant Rejection'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Plasma'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,996
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies funded by INDUSTRY in PHASE3 at Helsingborg, Sweden that involved Chorea Associated With Huntington Disease and BDP HFA Nasal Aerosol. Include primary and secondary outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDUSTRY'}) MATCH (study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Helsingborg, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Chorea Associated With Huntington Disease'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'BDP HFA Nasal Aerosol'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,997
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
Show studies conducted by Pfizer in Lund, Sweden involving Laryngeal Dystonia and BLOOD SAMPLE. Include collaborators and outcome details.
MATCH (study:Study)-[:SPONSORED_BY]->(sponsor:Sponsor {name: 'Pfizer'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Laryngeal Dystonia'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'BLOOD SAMPLE'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, collaborator.name
99,998
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies in PHASE3 funded by NETWORK at Kristianstad, Sweden involving Neurocognitive Dysfunction and Placebo to SHP-141C. Include outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE3'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'NETWORK'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Kristianstad, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Neurocognitive Dysfunction'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Placebo to SHP-141C'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
99,999
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies in PHASE4 funded by OTHER at Hangzhou, Zhejiang, China involving Alpha1-antitrypsin Deficiency and Weight loss. Include outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE4'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'OTHER'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Hangzhou, Zhejiang, China'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Alpha1-antitrypsin Deficiency'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Weight loss'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name
100,000
clinical_trials
Nodes: Study, Sponsor, Collaborator, Condition, Intervention, PrimaryOutcomeMeasures, SecondaryOutcomeMeasures, OtherOutcomeMeasures, StudyType, AgeGroup, Sex, Location, Phase, FunderType; Relationships: (:Study)-[:SPONSORED_BY]->(:Sponsor), (:Study)-[:COLLABORATED_WITH]->(:Collaborator), (:Study)-[:STUDIES]->(:Condition), (:Study)-[:INTERVENTION]->(:Intervention), (:Study)-[:MEASURES_PRIMARY_OUTCOME]->(:PrimaryOutcomeMeasures), (:Study)-[:MEASURES_SECONDARY_OUTCOME]->(:SecondaryOutcomeMeasures), (:Study)-[:MEASURES_OTHER_OUTCOME]->(:OtherOutcomeMeasures), (:Study)-[:TYPE_OF]->(:StudyType), (:Study)-[:INCLUDES_AGE_GROUP]->(:AgeGroup), (:Study)-[:INCLUDES_SEX]->(:Sex), (:Study)-[:CONDUCTED_AT]->(:Location), (:Study)-[:PHASE_OF]->(:Phase), (:Study)-[:FUNDED_BY]->(:FunderType)
List studies in PHASE1|PHASE2 funded by INDUSTRY at Lund, Sweden involving Recurrent Hypopharyngeal Squamous Cell Carcinoma and Combination therapy (S81694 + paclitaxel) phase I. Include outcomes, sponsors, and collaborators.
MATCH (study:Study)-[:PHASE_OF]->(phase:Phase {name: 'PHASE1|PHASE2'}) MATCH (study)-[:FUNDED_BY]->(funder:FunderType {name: 'INDUSTRY'}) MATCH (study)-[:CONDUCTED_AT]->(location:Location {name: 'Lund, Sweden'}) MATCH (study)-[:STUDIES]->(condition:Condition {name: 'Recurrent Hypopharyngeal Squamous Cell Carcinoma'}) MATCH (study)-[:INTERVENTION]->(intervention:Intervention {name: 'Combination therapy (S81694 + paclitaxel) phase I'}) MATCH (study)-[:MEASURES_PRIMARY_OUTCOME]->(primary:PrimaryOutcomeMeasures) MATCH (study)-[:MEASURES_SECONDARY_OUTCOME]->(secondary:SecondaryOutcomeMeasures) MATCH (study)-[:SPONSORED_BY]->(sponsor:Sponsor) MATCH (study)-[:COLLABORATED_WITH]->(collaborator:Collaborator) RETURN study.title, primary.name, secondary.name, sponsor.name, collaborator.name